KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biomarin Pharmaceutical (BMRN) Return on Invested Capital: 2010-2025

Historic Return on Invested Capital for Biomarin Pharmaceutical (BMRN) over the last 5 years, with Sep 2025 value amounting to 0.08%.

  • Biomarin Pharmaceutical's Return on Invested Capital rose 3.00% to 0.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08%, marking a year-over-year increase of 3.00%. This contributed to the annual value of 0.07% for FY2024, which is 4.00% up from last year.
  • Latest data reveals that Biomarin Pharmaceutical reported Return on Invested Capital of 0.08% as of Q3 2025, which was down 24.03% from 0.10% recorded in Q2 2025.
  • In the past 5 years, Biomarin Pharmaceutical's Return on Invested Capital ranged from a high of 0.10% in Q2 2025 and a low of -0.02% during Q4 2021.
  • Moreover, its 3-year median value for Return on Invested Capital was 0.04% (2024), whereas its average is 0.05%.
  • Data for Biomarin Pharmaceutical's Return on Invested Capital shows a peak YoY increased of 6bps (in 2025) over the last 5 years.
  • Over the past 5 years, Biomarin Pharmaceutical's Return on Invested Capital (Quarterly) stood at -0.02% in 2021, then increased by 5bps to 0.03% in 2022, then remained steady at 0.03% in 2023, then grew by 4bps to 0.07% in 2024, then climbed by 3bps to 0.08% in 2025.
  • Its last three reported values are 0.08% in Q3 2025, 0.10% for Q2 2025, and 0.08% during Q1 2025.